Chemical Compound

Karenitecin

CAS Registry Number 203923-89-1
Karenitecin chemical structure
Primary Record

Karenitecin

In stock
7,881 g
Purity
99.5 %
CAS
203923-89-1

Compound Identifiers & Properties

CAS
203923-89-1
PubChem CID
148202
SMILES
CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=C(C5=CC=CC=C5N=C4C3=C2)CC[Si](C)(C)C)O
Canonical SMILES
CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccccc1c2CC[Si](C)(C)C

Names & Synonyms

  • Karenitecin
  • Cositecan
  • Karentecin
  • cositecanum
  • 203923-89-1
  • Karenitecin (TN)
  • Cositecan [USAN]
  • Karenitecin (Cositecan)
  • Cositecan (USAN)
  • BNP1350
  • Cositecan;BNP 1350
  • Cositecan [USAN:INN]
  • COSITECAN [INN]
  • COSITECAN [MI]
  • UNII-24R60NVC41
  • BNP-1350
  • RefChem:128190
  • D02CZK
  • AC1L3WN8
  • COSITECAN [WHO-DD]
  • 24R60NVC41
  • BNP 1350
  • C25H28N2O4Si
  • DTXSID90174340
  • DB 172
  • orb1707518
  • SCHEMBL2315201
  • 7-Trimethylsilylethylcamptothecin
  • CHEMBL1997373
  • DTXCID2096831
  • SCHEMBL15419296
  • SCHEMBL29378211
  • CHEBI:177492
  • NSC710270
  • POADTFBBIXOWFJ-VWLOTQADSA-N
  • C25-H28-N2-O4-Si
  • CID148202
  • AKOS040741401
  • ZINC169746728
  • ACN-035786
  • DB05806
  • NSC-710270
  • 7-[2-(trimethylsilyl)ethyl]camptothecin
  • AN-29989
  • HY-14812
  • MS-28131
  • NCI60_038797
  • CS-0003573
  • NS00073515
  • J1.562.147H
  • D09327
  • G13583
  • Z-3161
  • 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-11-[2-(trimethylsilyl)ethyl]-, (4S)-
  • 923K891
  • A1006748
  • Q27095699
  • (19S)-19-ethyl-19-hydroxy-10-(2-trimethylsilylethyl)-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione
  • (4S)-4-Ethyl-4-hydroxy-11-(2-(trimethylsilyl)ethyl)-1,12-dihydro-14H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H)-dione
  • (S)-4-ethyl-4-hydroxy-11-(2-(trimethylsilyl)ethyl)-1,12-dihydro-14H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H)-dione
  • (S)-4-ethyl-4-hydroxy-11-(2-(trimethylsilyl)ethyl)-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione.
  • (19S)-19-ethyl-19-hydroxy-10-(2-(trimethylsilyl)ethyl)-17-oxa-3,13-diazapentacyclo(11.8.0.02,11.0?,?.01?,2?)henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione
  • (19S)-19-ethyl-19-hydroxy-10-[2-(trimethylsilyl)ethyl]-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione
  • (4S)-4-ETHYL-4-HYDROXY-11-(2-(TRIMETHYLSILYL)ETHYL)-1,12-DIHYDRO-14H- PYRANO(3',4':6,7)INDOLIZINO(1,2-B)QUINOLINE-3,14(4H)-DIONE
  • (4S)-4-Ethyl-4-hydroxy-11-(2-trimethylsilyl)ethyl)-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
  • (4S)-4-Ethyl-4-hydroxy-11-[2-(trimethylsilyl)ethyl]-1H-pyrano[3 inverted exclamation marka,4 inverted exclamation marka:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
  • (4S)-4-ethyl-4-hydroxy-11-[2-(trimethylsilyl)ethyl]-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
  • (4S)-4-Ethyl-4beta-hydroxy-11-[2-(trimethylsilyl)ethyl]-1H-pyrano[3 ,4 :6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
  • 1H-PYRANO(3',4':6,7)INDOLIZINO(1,2-B)QUINOLINE-3,14(4H,12H)-DIONE, 4-ETHYL-4-HYDROXY- 11-(2- (TRIMETHYLSILYL)ETHYL)-, (4S)-
  • 1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-11-(2-trimethylsilyl)ethyl)-, (4S)-